Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Yoshiharu Uruno
Introduction
Yoshiharu Uruno is a notable inventor based in Takarazuka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in the brain. His work is particularly relevant for treating conditions such as attention deficit hyperactivity disorder (ADHD).
Latest Patents
Yoshiharu Uruno holds a patent for a cyclic aminomethyl pyrimidine derivative. This invention provides a compound with high selectivity for dopamine D receptors, which are crucial in the treatment of ADHD. The patent describes a compound of formula (1) or a pharmaceutically acceptable salt thereof, with specific structural characteristics that enhance its therapeutic potential.
Career Highlights
Uruno is associated with Sumitomo Dainippon Pharma Co., Ltd., where he has been instrumental in advancing pharmaceutical research. His innovative approach has led to the development of new therapeutic agents that can significantly improve patient outcomes.
Collaborations
Throughout his career, Yoshiharu Uruno has collaborated with esteemed colleagues, including Hidefumi Yoshinaga and Hidetaka Nagata. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Yoshiharu Uruno's contributions to pharmaceutical innovation highlight the importance of targeted therapies in modern medicine. His work continues to pave the way for advancements in the treatment of neurological disorders.